Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 10.6B | 9.2B | 9.1B | 9.0B |
Cost of revenue | 8.8B | 7.2B | 7.3B | 7.4B |
Gross profit | 1.8B | 2.0B | 1.8B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.1B | 1.5B | 1.2B | 868.3M |
Non operating interest income | ||||
Income | 18.5M | 18.7M | 18.8M | 18.2M |
Expense | 15.2M | 16.6M | 17.5M | 18.2M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 1.5B | 1.1B | 878.0M |
Tax provision | 385.8M | 505.0M | 380.1M | 305.7M |
Net income | 701.2M | 948.6M | 707.0M | 572.3M |
Basic EPS | — | — | — | 6.7 |
Diluted EPS | — | — | — | 6.7 |
Basic average shares | — | — | — | 85.2M |
Diluted average shares | — | — | — | 85.2M |
EBITDA | 1.1B | 1.5B | 1.1B | 896.2M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |